Hormonal

A pragmatic prescribing pathway for liraglutide 3.0 mg using multiple stopping rules (≥5% weight loss at 16 weeks, ≥10% at 32 weeks, and ≥15% at 52 weeks) significantly increases the proportion of adults with obesity achieving ≥15% weight loss compared to standard specialist weight management services alone.

If you have a BMI of 35 or higher and conditions like high blood pressure or sleep apnea, ask your doctor about a specialized weight management program that includes liraglutide 3.0 mg. This medication is taken as a daily injection, starting at a low dose and increasing to 3 mg. A key part of this approach is 'stopping rules': if you don't lose enough weight at specific check-ups, the medication is stopped to save costs and avoid unnecessary side effects. This method helps ensure that only those who benefit continue treatment, leading to much better long-term weight loss results than lifestyle changes alone.